. Rapamycin prevents hypertrophy induced by rAAV6:BMP7. (a) IGF1 and IGF2 transcription was measured in TA muscles examined 28 d after administration of rAAV6:ALK3 (*, P = 0.005 vs. control; n = 4 per treatment). (b) FoxO1 T24 /FoxO3a T32 phosphorylation and total abundance was measured 28 d after rAAV6:BMP7 administration by Western blotting (P = ND). (c) Transcription of the E3 ubiquitin ligases atrogin1, MuRF1, and Musa1/ Fbxo30 was measured by RT-PCR in muscle examined 28 d after administration of rAAV6:BMP7. P = ND. (d) Representative H&E images demonstrate rapamycin prevents hypertrophy of myofibers otherwise caused by administration of rAAV6:BMP7. Bar, 100 µm. (e and f) BMP7 mRNA (n = 7-8 per treatment) and protein expression (n = 3 per treatment) were measured 28 d after rAAV6:BMP7 administration in the presence of rapamycin or vehicle. RT-PCR data are presented according to the CT method of analysis and normalized to a value of 1 (*, P = 0.008 vs. control; #, P = 0.02 vs. control). (g) The administration of rapamycin to mice did not prevent the phosphorylation of Smad1/5 in muscles administered rAAV6:BMP7 (n = 4 per treatment; *, P = 0.03 vs. control; #, P = 0.01 vs. control). Data are presented as means ± SEM. control; n = 6 per treatment), 7 d (n = 5-6 per treatment; *, P = 0.015 vs. control; #, P < 0.001 vs. denervation), and 14 d (n = 3-6 per treatment; *, P = 0.02 vs. control; #, P < 0.001 vs. denervation) after denervation via RT-PCR. (b-d) TA muscles were denervated and treated with rAAV6:HDAC4 D840N 8 d before analysis, at which time, muscle mass (*, P < 0.001 vs. control; #, P = 0.02 vs. denervation) and myofiber diameter (*, P < 0.001 vs. control; #, P = 0.004 vs. denervation) was assessed. n = 4-5 per treatment. Expression of the dominant-negative HDAC4 mutant in denervated muscle was readily detectable by Western blot. Myofiber diameter is presented as box and whisker plots comprising minimum, lower quartile, median, upper quartile, and maximum values. Bar, 100 µm. (e) Myogenin transcription was measured by RT-PCR in muscles examined 8 d after denervation while transduced with rAAV6:HDAC4 D840N or sham vector (*, P < 0.001 vs. control; #, P = 0.007 vs. den; n = 3-5 per treatment).
